Aztron Medtech’s TendMIN system has been used in more than 100 clinical cases, the company said in a Feb. 5 news release.
TendMIN is designed for percutaneous Achilles tendon repair through an incision of 1 centimeter or less. Brian Burgess, DPM, performed the milestone 100th case.
TendMIN earned FDA listing in 2025, and the company is continuing to expand surgeon training for the device.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
